<DOC>
	<DOC>NCT00721903</DOC>
	<brief_summary>The purpose of this study is to determine how well changes can be determined in malignant masses from ultrasound scans.</brief_summary>
	<brief_title>Three Dimensional (3D) Ultrasound in Predicting Response to Breast Cancer Therapies</brief_title>
	<detailed_description>To evaluate the proportions of correct diagnosis of response to breast Cancer therapies for localized breast cancer by ultrasound. To develop a model based on patient characteristics, physical exam, and radiologic studies which will predict the possibility that a patient has had a complete pathological response to chemotherapy neoadjuvant therapy.</detailed_description>
	<mesh_term>Breast Neoplasms</mesh_term>
	<criteria>Newly diagnosed breast cancer prior to receiving breast cancer therapy. Diagnosis of breast cancer must be confirmed by fine needle aspiration or core biopsy. Poorly controlled diabetes. Contralateral mastectomy prior to neoadjuvant chemotherapy. Not a surgical candidate. No previous axillary lymph node dissection.</criteria>
	<gender>Female</gender>
	<minimum_age>25 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2016</verification_date>
</DOC>